Pertuzumab and the Curious Case of Accelerated Registration

Drs Kathy Miller, Clifford Hudis, and George Sledge discuss the pros and cons of testing novel breast cancer treatments in the neoadjuvant setting, with special reference to pertuzumab.

Source: Medscape Oncology - February 9, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts